Report overview
This report contains market size and forecasts of Kidney Cancer Diagnosis in global, including the following market information:
Global Kidney Cancer Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Kidney Cancer Diagnosis Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Kidney Cancer Diagnosis companies in 2021 (%)
The global Kidney Cancer Diagnosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunohistochemical Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Kidney Cancer Diagnosis include Myriad Genetics Inc., NeoGenomics Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Rosetta Genomics, Illumina Inc., Abbott Laboratories and Roche Holding AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney Cancer Diagnosis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Cancer Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Kidney Cancer Diagnosis Market Segment Percentages, by Type, 2021 (%)
Immunohistochemical Test
Complete Blood Count Test
Urine Test
Blood Chemistry Test
Global Kidney Cancer Diagnosis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Kidney Cancer Diagnosis Market Segment Percentages, by Application, 2021 (%)
Hospital
Surgery Center
Global Kidney Cancer Diagnosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Kidney Cancer Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney Cancer Diagnosis revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Kidney Cancer Diagnosis revenues share in global market, 2021 (%)
Key companies Kidney Cancer Diagnosis sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Kidney Cancer Diagnosis sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Myriad Genetics Inc.
NeoGenomics Laboratories
Thermo Fisher Scientific Inc.
Sysmex Corporation
Rosetta Genomics
Illumina Inc.
Abbott Laboratories
Roche Holding AG
